![]() |
市場調查報告書
商品編碼
1684828
玻璃體視網膜手術設備市場機會、成長動力、產業趨勢分析與預測 2025 - 2034Vitreoretinal Surgery Devices Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034 |
2024 年全球玻璃體視網膜手術設備市場價值為 17 億美元,預計 2025 年至 2034 年的複合年成長率為 3.4%。這一成長主要得益於視網膜疾病發病率的上升,包括老年性黃斑部病變、糖尿病視網膜病變和視網膜剝離,隨著全球人口老化,這些疾病變得越來越常見。此外,人們對微創手術的日益偏好推動了對尖端玻璃體視網膜設備的需求,因為與傳統手術方法相比,這些手術往往能提供更快的恢復時間並減少患者的不適。門診手術數量的不斷成長也是這一趨勢的關鍵因素,因為患者和醫療保健提供者越來越青睞具有成本效益、快速的手術,以避免長期住院。
政府和私營部門旨在提高人們的認知和改善視網膜疾病治療可近性的舉措極大地促進了該市場的擴張。以早期診斷為重點的公共衛生運動以及及時介入的重要性的教育,正在幫助更多人了解這些先進外科治療的必要性。此外,許多已開發國家提供的醫療保險和報銷選項減少了財務障礙,使更多患者能夠選擇這些必要的手術。因此,認知度和可負擔性在推動玻璃體視網膜手術設備的採用方面發揮關鍵作用。
市場範圍 | |
---|---|
起始年份 | 2024 |
預測年份 | 2025-2034 |
起始值 | 17億美元 |
預測值 | 24億美元 |
複合年成長率 | 3.4% |
市場多種多樣,各種產品促進其成長。主要部分包括玻璃體切除術探頭、玻璃體視網膜包、玻璃體切除術機器、照明設備、光凝固雷射和其他相關產品。其中,玻璃體視網膜包在 2024 年的收入為 6.021 億美元,成為一個重要的市場區隔。這些包因其便利性而受到高度重視,因為它們包含預先組裝的、消毒的儀器和消耗品,無需單獨採購和消毒。這不僅節省了時間,還提高了醫療保健提供者的營運效率,降低了醫院和診所的準備成本。
在外科手術方面,後玻璃體視網膜手術領域可望大幅成長。預計到 2034 年該領域市場規模將達到 19 億美元,主要得益於高速玻璃體切除機的進步、增強的術中成像以及更小、更精確的儀器的開發。這些創新提高了後段手術的效率和安全性,使其成為外科醫生和患者更有吸引力的選擇。
在美國,玻璃體視網膜手術設備市場規模在 2024 年達到 6.595 億美元,預計到 2034 年將以 2.7% 的複合年成長率成長。這一成長得益於先進成像技術的日益普及,例如光學相干斷層掃描 (OCT) 和即時視網膜成像,這些技術為外科醫生在手術過程中提供了無與倫比的精確度。隨著公眾對視網膜疾病認知的提高和診斷工具的改進,越來越多的患者尋求透過手術來保留或恢復視力,進一步推動了對這些專用設備的需求。
The Global Vitreoretinal Surgery Devices Market, valued at USD 1.7 billion in 2024, is set to experience a CAGR of 3.4% from 2025 to 2034. This growth is largely driven by the rising prevalence of retinal diseases, including age-related macular degeneration, diabetic retinopathy, and retinal detachment, which are becoming more common as populations age worldwide. Additionally, the increasing preference for minimally invasive surgical options is pushing the demand for cutting-edge vitreoretinal devices, as these procedures tend to offer faster recovery times and reduced patient discomfort compared to traditional surgical methods. The growing number of outpatient surgeries is also a key factor in this trend, as patients and healthcare providers increasingly favor cost-effective, quick procedures that avoid long hospital stays.
Government and private sector initiatives aimed at raising awareness and improving accessibility to retinal disease treatments are significantly contributing to the expansion of this market. Public health campaigns focused on early diagnosis, along with education about the importance of timely intervention, are helping more people understand the need for these advanced surgical treatments. Moreover, the availability of healthcare coverage and reimbursement options in many developed countries is reducing financial barriers, allowing more patients to opt for these necessary surgeries. As a result, both awareness and affordability are playing pivotal roles in driving the adoption of vitreoretinal surgery devices.
Market Scope | |
---|---|
Start Year | 2024 |
Forecast Year | 2025-2034 |
Start Value | $1.7 Billion |
Forecast Value | $2.4 Billion |
CAGR | 3.4% |
The market is diverse, with a range of products contributing to its growth. Key segments include vitrectomy probes, vitreoretinal packs, vitrectomy machines, illumination devices, photocoagulation lasers, and other related products. Among these, vitreoretinal packs generated USD 602.1 million in 2024, making them a significant segment. These packs are highly valued for their convenience, as they contain pre-assembled, sterilized instruments and consumables, eliminating the need for separate procurement and sterilization. This not only saves time but also enhances operational efficiency for healthcare providers, reducing preparation costs for hospitals and clinics.
In terms of surgical procedures, the posterior vitreoretinal surgery segment is poised for substantial growth. Expected to reach USD 1.9 billion by 2034, this segment is driven by advancements in high-speed vitrectomy machines, enhanced intraoperative imaging, and the development of smaller, more precise instruments. These innovations have improved the efficiency and safety of posterior segment surgeries, making them a more appealing option for surgeons and patients alike.
In the U.S., the vitreoretinal surgery devices market reached USD 659.5 million in 2024 and is projected to grow at a CAGR of 2.7% through 2034. This growth is fueled by the increasing adoption of advanced imaging technologies, such as optical coherence tomography (OCT) and real-time retinal imaging, which offer surgeons unparalleled precision during procedures. As public awareness of retinal diseases increases and diagnostic tools improve, more patients are seeking surgical options to preserve or restore their vision, further driving demand for these specialized devices.